Robert J. Flanagan

Robert J. Flanagan was elected to W. P. Carey’s Board of Directors in 2018 and serves as a member of the Audit Committee and Investment Committee. Mr. Flanagan is Executive Chair of Clark Enterprises Inc., a private investment firm with a diversified portfolio of holdings including real estate and private equity. Previously, he served as the Chief Executive Officer, President, and Executive Vice President at Clark Enterprises, where he oversaw the firm's investment portfolio as managing director of CNF Investments. Mr. Flanagan serves on the Boards of Directors of Brown Advisory, Svelte Medical Systems, and Vascular Therapies. He is also a member of the Board of Advisors of Georgetown University's McDonough School of Business. He is a board member of the A. James & Alice B. Clark Foundation, which invests in engineering education and veteran support in the Washington, D.C. community, and oversees the effort in vetting organizations that provide substantive services to U.S. military veterans and their families.

Mr. Flanagan previously served as Chair and member of the Board of Directors of Washington, D.C.’s Federal City Council, member of the Board of Directors of two publicly traded companies, Martek Biosciences Corporation and Sagent Pharmaceuticals, member of the Board of Directors of three private companies, Clark Equity Investors, Inc., Development Insurance Group, Inc., and Verax Biomedical, and Treasurer and member of the Board of Directors of Baltimore Orioles, Inc.

Mr. Flanagan received a BS in Business Administration from Georgetown University and an MST from the American University School of Business. He is a Certified Public Accountant licensed in Washington, D.C.